Word

AMGEN

Status

Registered

Status Code

700

Status Date

Tuesday, June 16, 2020

Serial Number

86834490

Registration Number

6080333

Registration Date

Tuesday, June 16, 2020

Mark Type

4000

Filing Date

Monday, November 30, 2015

Published for Opposition

Tuesday, August 16, 2016

Trademark Owner History

Amgen Inc. - Original Registrant

Classifications

5 Pharmaceuticals for the treatment of cardiovascular, cancer, bone, neurological nephrological and inflammation disease and disorders; pharmaceutical preparations for the treatment of anemia, ankylosing spondylitis, arthritis, cancer, cardiovascular conditions, collection by leukopheresis, effects of myelosuppressive chemotherapy, effects of myelosuppressive doses of radiation, glandular disorders, hormone disorders, hypercalcemia, hyperparathyroidism, hyperphosphatemia, kidney disorders and disease, migraine, neutropenia, osteoporosis, parathyroid disorders, psoriasis, reduction of red blood cell transfusions, renal disorders, thrombocytopenia; prescription pharmaceuticals for the treatment of anemia, ankylosing spondylitis, arthritis, cancer, cardiovascular conditions, collection by leukopheresis, effects of myelosuppressive chemotherapy, effects of myelosuppressive doses of radiation, glandular disorders, hormone disorders, hypercalcemia, hyperparathyroidism, hyperphosphatemia, kidney disorders and disease, migraine, neutropenia, osteoporosis, parathyroid disorders, psoriasis, reduction of red blood cell transfusions, renal disorders, thrombocytopenia; and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith

10 Drug delivery devices in the nature of drug delivery systems; drug delivery systems; injection device for pharmaceutical preparations; injectors for medical purposes in the nature of medical fluid injectors

35 Online wholesale services by direct solicitation by salespersons directed to end-users featuring pharmaceuticals; referral services in the field of treatment for cancer, chemotherapy and pharmaceutical products in the nature of medical referrals; business administration of prescription drug co-payment programs; business administration of patient reimbursement programs; referral services in the field of co-pay assistance programs in the nature of providing insurance agent referrals; providing an online commercial information directory in the field of patient support featuring information regarding healthcare providers, sites at which subcutaneous injections could be administered and retail pharmacies or specialty pharmacies where patients could obtain pharmaceutical preparations

36 Providing healthcare administration, namely, providing insurance verification and prior authorization services for others

41 Educational services, namely, development and dissemination of printed educational materials of others in the fields of pharmaceutical products and treatment of medical disorders; conducting seminars in the field of the use of prescription pharmaceutical products for medical disorders; educational and entertainment services, namely, providing a motivational and educational speaker featuring information regarding medical disorders; training services in the field of patient support services relating to treatment of medical disorders; providing on-line electronic newsletters delivered by email in the field of the treatment of medical disorders

42 Pharmaceutical research and development services; biological research; chemical research; medical research, namely, conducting clinical trials for others

44 Patient support services relating to the treatment of medical disorders, namely, providing online information in the field of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services via a global computer network; providing health and medical information about medical disorders; information services, namely, providing medical information to cancer patients; providing patient support services relating to cancer and cancer treatment in the nature of an Internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing information about bone health in patients with cancer by offering customized medical information and practical advice for communicating about bone health with healthcare providers; information services, namely, providing medical consultancy and advisory services via a global computer network in the field of cancer-related bone health; providing medical information and patient support services, namely, providing pharmaceutical advice and consultation in the nature of providing online information regarding bone health, the prevention of osteoporosis and the treatment and management of osteoporosis and bone disease, and pharmaceutical preparations for the treatment of osteoporosis; medical report services in the nature of providing medical reports regarding patients being treated for osteoporosis and bone disease; providing medical consultancy and advisory services via a global computer network in the field of cancer treatment and chemotherapy; providing medical information and patient support services, namely, pharmaceutical advice and consultation in the nature of providing online information regarding immune thrombocytopenic purpura; providing health and medical information about immune thrombocytopenic purpura; information services, namely, providing medical information to immune thrombocytopenic purpura patients; patient support services relating to treatment of medical disorders, namely, providing information to patients and families of patients in the field of administering medication, and patient medical information where patients can inquire about medical issues and procedures from medical personnel

Trademark Events

Jun 16, 2020

Registered-Principal Register

May 15, 2020

Notice Of Acceptance Of Statement Of Use E-Mailed

May 14, 2020

Allowed Principal Register - Sou Accepted

Apr 29, 2020

Teas/Email Correspondence Entered

Apr 28, 2020

Correspondence Received In Law Office

Apr 28, 2020

Teas Response To Office Action Received

Oct 28, 2019

Notification Of Non-Final Action E-Mailed

Oct 28, 2019

Non-Final Action E-Mailed

Oct 28, 2019

Su - Non-Final Action - Written

Oct 12, 2019

Statement Of Use Processing Complete

Oct 10, 2019

Use Amendment Filed

Oct 10, 2019

Teas Statement Of Use Received

Apr 4, 2019

Notice Of Approval Of Extension Request E-Mailed

Apr 3, 2019

Extension 5 Granted

Mar 28, 2019

Extension 5 Filed

Mar 28, 2019

Teas Extension Received

Mar 7, 2019

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 7, 2019

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Sep 11, 2018

Notice Of Approval Of Extension Request E-Mailed

Sep 7, 2018

Extension 4 Granted

Sep 7, 2018

Extension 4 Filed

Sep 7, 2018

Teas Extension Received

Aug 2, 2018

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 2, 2018

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 16, 2018

Notice Of Approval Of Extension Request E-Mailed

Mar 15, 2018

Extension 3 Granted

Mar 13, 2018

Extension 3 Filed

Mar 13, 2018

Teas Extension Received

Sep 13, 2017

Notice Of Approval Of Extension Request E-Mailed

Sep 12, 2017

Extension 2 Granted

Aug 31, 2017

Extension 2 Filed

Sep 12, 2017

Case Assigned To Intent To Use Paralegal

Aug 31, 2017

Teas Extension Received

Mar 29, 2017

Notice Of Approval Of Extension Request E-Mailed

Mar 27, 2017

Extension 1 Granted

Mar 27, 2017

Extension 1 Filed

Mar 27, 2017

Teas Extension Received

Oct 11, 2016

Noa E-Mailed - Sou Required From Applicant

Aug 16, 2016

Official Gazette Publication Confirmation E-Mailed

Aug 16, 2016

Published For Opposition

Jul 27, 2016

Notification Of Notice Of Publication E-Mailed

Jul 14, 2016

Approved For Pub - Principal Register

Jul 13, 2016

Examiner's Amendment Entered

Jul 13, 2016

Notification Of Examiners Amendment E-Mailed

Jul 13, 2016

Examiners Amendment E-Mailed

Jul 13, 2016

Examiners Amendment -Written

May 11, 2016

Notification Of Final Refusal Emailed

May 11, 2016

Final Refusal E-Mailed

May 11, 2016

Final Refusal Written

Apr 21, 2016

Teas/Email Correspondence Entered

Apr 20, 2016

Correspondence Received In Law Office

Apr 20, 2016

Teas Response To Office Action Received

Jan 8, 2016

Notification Of Non-Final Action E-Mailed

Jan 8, 2016

Non-Final Action E-Mailed

Jan 8, 2016

Non-Final Action Written

Jan 7, 2016

Assigned To Examiner

Dec 4, 2015

New Application Office Supplied Data Entered In Tram

Dec 3, 2015

New Application Entered In Tram